# Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution

> **NCT02577718** · PHASE1,PHASE2 · COMPLETED · sponsor: **Novel Anti-Infective Technologies, LLC** · enrollment: 60 (actual)

## Conditions studied

- Catheter-Associated Infections
- Catheter-Related Infections

## Interventions

- **DRUG:** Nitroglycerin-citrate-ethanol (NiCE)

## Key facts

- **NCT ID:** NCT02577718
- **Lead sponsor:** Novel Anti-Infective Technologies, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-06-22
- **Final completion:** 2016-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02577718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02577718, "Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02577718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*